Intrauterine growth restriction

How to manage and when to deliver

Giancarlo Mari, Farhan Hanif

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Intrauterine growth restriction secondary to placental insufficiency is a major cause of perinatal morbidity and mortality in the United States. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the results of cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management.

Original languageEnglish (US)
Pages (from-to)497-509
Number of pages13
JournalClinical Obstetrics and Gynecology
Volume50
Issue number2
DOIs
StatePublished - Jun 1 2007

Fingerprint

Fetus
Growth
Cardiotocography
Placental Insufficiency
Perinatal Mortality
Morbidity
Safety

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Intrauterine growth restriction : How to manage and when to deliver. / Mari, Giancarlo; Hanif, Farhan.

In: Clinical Obstetrics and Gynecology, Vol. 50, No. 2, 01.06.2007, p. 497-509.

Research output: Contribution to journalArticle

@article{d3a0394d78914bdba246c36f3dcecb26,
title = "Intrauterine growth restriction: How to manage and when to deliver",
abstract = "Intrauterine growth restriction secondary to placental insufficiency is a major cause of perinatal morbidity and mortality in the United States. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the results of cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management.",
author = "Giancarlo Mari and Farhan Hanif",
year = "2007",
month = "6",
day = "1",
doi = "10.1097/GRF.0b013e31804c96a9",
language = "English (US)",
volume = "50",
pages = "497--509",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Intrauterine growth restriction

T2 - How to manage and when to deliver

AU - Mari, Giancarlo

AU - Hanif, Farhan

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Intrauterine growth restriction secondary to placental insufficiency is a major cause of perinatal morbidity and mortality in the United States. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the results of cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management.

AB - Intrauterine growth restriction secondary to placental insufficiency is a major cause of perinatal morbidity and mortality in the United States. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the results of cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management.

UR - http://www.scopus.com/inward/record.url?scp=34249914521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249914521&partnerID=8YFLogxK

U2 - 10.1097/GRF.0b013e31804c96a9

DO - 10.1097/GRF.0b013e31804c96a9

M3 - Article

VL - 50

SP - 497

EP - 509

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 2

ER -